Full Paper
ously.[22] The crude reaction mixture was pre-purified on silica gel
126.6 (2CH), 127.4 (2CH), 127.7 (2CH), 127.8 (2CH), 128.3 (2CH),
(n-hexane/ethyl acetate, 8:2) yielding 304 mg of the diastereomeric 129.15 (2CH), 131.4 (2Cq), 131.6 (2Cq), 131.7 (d3J13C–31P = 3.3 Hz, 2Cq,
mixture of 6a–c (yield 80 %). The three diastereoisomers were than ), 132.3 (2Cq), 132.35 (2Cq), 132.6 (2Cq), 132.7 (2CH), 135.3 (2Cq),
2
isolated by semipreparative HPLC on Phenomenex® Kinetex C18 col-
145.9 (d, 2Cq, J13C–31P = 9.6 Hz) ppm. 31P NMR (161.9 MHz, CDCl3,
umn (250 × 20 mm, 5 μm; 20 mL/min; 254 nm UV detection; aceto- 25 °C): δ = 2.40 (bs) ppm.
nitrile/H2O, 85:15 v/v as eluent).
1
Compound 4b: H NMR (600 MHz, CDCl3, 25 °C): δ = 1.95 (s, 3 H),
Compound 6a: Retention time: 16.25 min. 1H NMR (600 MHz,
CD3CN, 25 °C): δ = 2.36 (s, 6 H), 6.19 (s, 2 H), 7.36–7.39 (m, 2 H),
7.39–7.45 (m, 4 H), 7.45–7.51 (m, 4 H), 7.54 (d, J = 8.3 Hz, 2 H), 7.57–
7.61 (m, 2 H), 7.87 (s, 1 H), 7.92 (d, J = 8.3 Hz, 2 H), 7.93–7.96 (m, 4
H) ppm. 13C NMR (150.8 MHz, CD3CN, 25 °C): δ = 20.0 (2C3), 114.1
(2Cq), 123.8 (2CH), 124.2 (2CH), 125.1 (2CH), 125.6 (2CH), 126.35
(2CH), 126.9 (2CH), 127.9 (2CH), 128.0 (2CH), 128.2 (2CH), 128.8
(2CH), 128.9 (2Cq), 129.6 (2Cq), 131.5 (2CH), 132.3 (2Cq), 133.3 (2Cq),
133.8 (2Cq), 134.2 (2Cq), 135.0 (2Cq), 151.8 (2Cq) ppm. HRMS (ESI-
Orbitrap M-H): m/z calcd. for C42H29O2: 565.2173; found 565.2171.
2.18 (s, 3 H), 6.93 (d, J = 8.3 Hz, 1 HAr), 7.08 (d, J = 8.4 Hz, 1 HAr),
7.17 (t, J = 7.8 Hz, 1 HAr), 7.22 (t, J = 7.3 Hz, 2 HAr), 7.27 (d, J =
8.5 Hz, 1 HAr), 7.31 (t, J = 7.3 Hz, 1 HAr), 7.37 (d, J = 8.4 Hz, 1 HAr),
7.41 (d, J = 8.5 Hz, 1 HAr), 7.42–7.48 (m, 3 HAr), 7.53–7.61 (m, 5 HAr),
7.68 (d, J = 8.2 Hz, 1 HAr), 7.86 (s, 1 HAr), 7.90 (s, 1 HAr), 7.94 (d, J =
7.8 Hz, 1 HAr), 7.99 (d, J = 8.3 Hz, 1 HAr) ppm. 13C NMR (150.8 MHz,
3
CDCl3, 25 °C): δ = 21.15 (1CH3), 29.7 (1CH3), 122.2 (d, J13C–31P
=
2.23 Hz, 1Cq), 122.3 (d, 3J13C–31P = 2.2 Hz, 1Cq), 124.25, 124.5, 125.3,
125.4, 125.85, 125.9, 126.1, 126.35, 126.56, 126.61, 127.2, 127.3, 127.4,
127.74, 127.79, 127.86, 127.95, 128.3, 128.5, 128.9, 131.34, 131.46,
131.54, 131.56, 131.65, 131.87, 131.91, 131.93, 132.18, 132.22, 132.3,
Compound 6b: Retention time: 17.05 min. 1H NMR (600 MHz,
CD3CN, 25 °C): δ = 2.33 (s, 3 H), 2.40 (s, 3 H), 6.23 (s, 1 H), 6.25 (s, 1
H), 7.27–7.30 (m, 1 H), 7.34–7.43 (m, 6 H), 7.43–7.47 (m, 1 H), 7.47–
7.50 (m, 2 H), 7.53 (d, J = 8.6 Hz, 1 H), 7.56 (d, J = 8.4 Hz, 1 H), 7.58–
7.61 (m, 1 H), 7.67 (d, J = 8.6 Hz, 1 H), 7.87 (s, 2 H), 7.90–7.96 (m, 6
H) ppm. 13C NMR (150.8 MHz, CD3CN, 25 °C): δ = 20.0 (1C3), 30.0
(1C3), 114.0 (1Cq), 114.1 (1Cq), 123.8 (1CH), 123.8 (1CH), 124.1 (1CH),
124.2 (1CH), 125.1 (2CH), 125.65 (1CH), 125.9 (1CH), 126.1 (1CH),
126.35 (1CH), 126.9 (1CH), 127.0 (1CH), 127.8 (1CH), 127.9 (1CH),
127.9 (1CH), 128.0 (1CH), 128.25 (1CH), 128.3 (1CH), 128.8 (1CH),
128.8 (1CH), 128.9 (1Cq), 128.9 (1Cq), 129.6 (1Cq), 129.6 (1Cq), 131.5
(1CH), 131.5 (1CH), 132.3 (1Cq), 132.3 (1Cq), 133.3 (2Cq), 133.9 (2Cq),
134.15 (1Cq), 134.2 (1Cq), 134.9 (1Cq), 135.0 (1Cq), 151.8 (1Cq), 151.9
(1Cq) ppm. HRMS (ESI-Orbitrap, M-H): m/z calcd. for C42H29O2:
565.2173; found 565.2170.
2
132.5, 132.75, 132.95, 134.5, 135.1, 145.7 (d, J13C–31P = 8.9 Hz, 1Cq),
145.9 (d, J13C–31P = 8.9 Hz, 1Cq) ppm. 31P NMR (161.9 MHz, CDCl3,
2
25 °C): δ = 2.20 (bs) ppm.
1
Compound 4c: H NMR (600 MHz, CDCl3, 25 °C): δ = 2.09 (s, 6 H),
7.14 (t, J = 7.5 Hz, 2 HAr), 7.19 (d, J = 8.5 Hz, 2 HAr), 7.41–7.28 (m,
6 HAr), 7.51–7.59 (m, 8 HAr), 7.88 (s, 2 HAr), 7.97 (d, J = 8.1 Hz, 2
HAr) ppm. 13C NMR (150.8 MHz, CDCl3, +25 °C): δ = 20.5 (2C3), 122.4
3
(d, J13C–31P = 2.2 Hz, 2Cq), 124.4 (2CH), 125.35 (2CH), 125.8 (2CH),
126.6 (2CH), 126.8 (2CH), 127.1 (2CH), 127.2 (2CH), 127.65 (2CH),
128.3 (2CH), 128.4 (2CH), 131.35 (2Cq), 131.7 (d3J13C–31P = 2.7 Hz,
2Cq, ), 131.8 (2Cq), 132.1 (2Cq), 132.3 (2Cq), 132.7 (2CH), 132.9 (2Cq),
2
134.65 (2Cq), 145.95 (d, J13C–31P = 9.1 Hz, 2Cq) ppm. 31P NMR
(161.9 MHz, CDCl3, 25 °C): δ = 2.07 (bs) ppm.
(2S,4S)-4-(1H-Indol-2-yl)-6-methoxy-2-phenyl-1,2,3,4-tetra-
hydroquinoline (9):[19a] To a flame-dried Schlenk tube equipped
with a magnetic stirring bar, 3 Å spherical-shaped molecular sieves
(ca. 70 mg) were added under a N2 atmosphere. The molecular
sieves were thermally activated under vacuum for 10 min and then
cooled to room temp. The Schlenk tube was backfilled with N2, then
aldimine 7 (5.3 mg, 0.025 mmol) was added, followed by catalyst 4
(1.5 mg, 0.0025 mmol, 10 mol-%) and anhydrous toluene (0.5 mL).
After heating to 45 °C, 2-vinylindole 8 (3.9 mg, 0.0275 mmol) was
added. The mixture was then stirred at the same temperature under
a N2 atmosphere. After 3 h, the reaction mixture was diluted with
CH2Cl2 and filtered through a plug of silica gel, and the plug was
washed with EtOAc (4 ×). After concentration of the solvents, the
residue was analyzed by 1H NMR spectroscopy to determine the
conversion of the reaction and the diastereomeric ratio of the cy-
cloadduct 9 (>9:1 in all cases). 1H NMR (300 MHz, CDCl3, 25 °C): δ =
2.31 (br. q, J = 11.7 Hz, 1 H), 2.41 (ddd, J = 13.2, 6.2, 2.7 Hz, 1 H),
3.59 (s, 3 H), 6.59 (br. s, 1 H), 6.67–6.72 (m, 1 H), 7.07–7.16 (m, 2 H),
7.22–7.26 (m, 1 H), 7.28–7.35 (m 1 H), 7.35–7.41 (m, 2 H), 7.44–7.49
(m, 2 H), 7.55–7.60 (m, 1 H), 7.89 (br. s, 1 H) ppm. CSP-HPLC (Daicel
Chiralcel® OD; n-hexane/isopropane, 80:20 v/v; 1 mL/min; room
temp.): tR = 15.9 (major), 18.9 (minor) min.
Compound 6c: Retention time: 17.75 min. 1H NMR (600 MHz,
CD3CN, 25 °C): δ = 2.41 (s, 6 H), 6.26 (s, 2 H), 7.27–7.34 (m, 4 H),
7.37–7.45 (m, 6 H), 7.57 (d, J = 8.4 Hz, 2 HAr), 7.64 (d, J = 8.4 Hz, 2
H), 7.87 (s, 2 H), 7.90–7.96 (m, 6 H) ppm. 13C NMR (150.8 MHz,
CD3CN, 25 °C): δ = 20.0 (2CH3), 114.0 (2Cq), 123.8 (2CH), 124.0 (2CH),
125.05 (2CH), 125.9 (2CH), 126.1 (2CH), 127.0 (2CH), 127.85 (2CH),
127.9 (2CH), 128.3 (2CH), 128.8 (2CH), 128.95 (2Cq), 129.6 (2Cq), 131.5
(2CH), 132.3 (2Cq), 133.3 (2Cq), 134.0 (2Cq), 134.1 (2Cq), 134.9 (2Cq),
151.9 (2Cq) ppm. HRMS (ESI-Orbitrap, M-H): m/z calcd. for C42H29O2:
565.2173; found 565.2169.
General Procedure for the Preparation of 4a–c:[18] To compound
6a–c ( 20 mg, 1 equiv., 0.035 mmol) dissolved in anhydrous pyr-
idine, POCl3 (3.4
M in pyridine, 0.16 mL, 0.54 mmol, 15 equiv.) was
slowly added under a positive nitrogen flux. The stirred mixture was
kept at 60 °C until disappearance of the starting compound (16–
20 h), then H2O (1 mL) was added and the mixture was stirred and
heated at 60 °C for an additional 3 h. HCl (3
added to the cooled solution and stirring was continued for 3 h.
The mixture was diluted with CH2Cl2, washed with HCl (3 , 3 ×
M, 1 mL) was then
M
20 mL) and then dried on Na2SO4. The crude material was purified
on silica gel (CH2Cl2 then gradient to CH2Cl2/CH3OH, 9:1) to give
compound 4a–c (yields 70–80 %). Spectroscopic characterization
Benzyl {(E)-2-[(2S,4R)-6-Methoxy-2-phenyl-1,2,3,4-tetrahydro-
quinolin-4-yl]vinyl}carbamate (11):[17] To a flame-dried Schlenk
tube equipped with a magnetic stirring bar, 4 Å powdered molec-
ular sieves (ca. 20 mg) were added under a N2 atmosphere. The
molecular sieves were thermally activated under vacuum for 5 min
was performed after stirring the pure compound in 3
M HCl for 1 h
followed by extraction with CH2Cl2 and drying on Na2SO4.
1
Compound 4a: H NMR (600 MHz, CDCl3, 25 °C): δ = 2.11 (s, 6 H),
6.96 (d, J = 7.9 Hz, 2 HAr), 7.22–7.29 (m, 4 HAr), 7.31–7.38 (m, 4 HAr), and then cooled to room temp. After backfilling the Schlenk tube
7.41–7.45 (m, 2 HAr), 7.53–7.60 (m, 4 HAr), 7.75 (d, J = 8.0 Hz, 2 HAr), with N2, aldimine 7 (5.3 mg, 0.025 mmol), catalyst 8 (0.8 mg,
7.87 (s, 2 HAr), 7.94 (d, J = 8.2 Hz, 2 HAr) ppm. 13C NMR (150.8 MHz, 0.00125 mmol, 5 mol-%), and toluene (100 μL) were added. The
3
CDCl3, 25 °C): δ = 21.0 (1CH3), 29.7 (1CH3), 122.2 (d, J13C–31P
=
mixture was stirred for 5 min, then diene 10 (7.6 mg, 0.0375 mmol)
2.3 Hz, 2Cq), 124.6 (2CH), 125.45 (2CH), 125.9 (2CH), 126.1 (2CH), was added. The mixture was stirred at room temp. under a N2 at-
Eur. J. Org. Chem. 0000, 0–0
8
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim